BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27931034)

  • 1. Historical Perspective on Clinical Trials of Carnitine in Children and Adults.
    Buist NR
    Ann Nutr Metab; 2016; 68 Suppl 3():1-4. PubMed ID: 27931034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Round Table Discussion.
    Winter S; Buist NR; Longo N; Armenian SH; Lopaschuk G; Wasilewska A
    Ann Nutr Metab; 2016; 68 Suppl 3():21-23. PubMed ID: 27931031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Carnitine Deficiency and Newborn Screening for Disorders of the Carnitine Cycle.
    Longo N
    Ann Nutr Metab; 2016; 68 Suppl 3():5-9. PubMed ID: 27931018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy.
    Mamedov I; Zolkina I; Nikolaeva E; Glagovsky P; Sukhorukov V
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1299-304. PubMed ID: 26197467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine Inborn Errors of Metabolism.
    Almannai M; Alfadhel M; El-Hattab AW
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31500110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review about prophylactic L-carnitine administration in parenteral nutrition of extremely preterm infants.
    Salguero Olid A; Blanco Sánchez G; Alonso Ojembarrena A
    Farm Hosp; 2018 Jul; 42(4):168-173. PubMed ID: 29959842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approaches.
    Ryder B; Inbar-Feigenberg M; Glamuzina E; Halligan R; Vara R; Elliot A; Coman D; Minto T; Lewis K; Schiff M; Vijay S; Akroyd R; Thompson S; MacDonald A; Woodward AJM; Gribben JEL; Grunewald S; Belaramani K; Hall M; van der Haak N; Devanapalli B; Tolun AA; Wilson C; Bhattacharya K
    J Inherit Metab Dis; 2021 Jul; 44(4):903-915. PubMed ID: 33634872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.
    Maruyama T; Maruyama N; Higuchi T; Nagura C; Takashima H; Kitai M; Utsunomiya K; Tei R; Furukawa T; Yamazaki T; Okawa E; Ando H; Kikuchi F; Abe M
    Eur J Clin Nutr; 2019 Feb; 73(2):293-301. PubMed ID: 30353121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.
    Vasiljevski ER; Burns J; Bray P; Donlevy G; Mudge AJ; Jones KJ; Summers MA; Biggin A; Munns CF; McKay MJ; Baldwin JN; Little DG; Schindeler A
    Am J Med Genet A; 2021 Oct; 185(10):2976-2985. PubMed ID: 34155781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine supplementation for inborn errors of metabolism.
    Nasser M; Javaheri H; Fedorowicz Z; Noorani Z
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006659. PubMed ID: 19370646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular in vitro probe acylcarnitine assay for identifying deficiencies of carnitine transporter and carnitine palmitoyltransferase-1.
    Purevsuren J; Kobayashi H; Hasegawa Y; Yamada K; Takahashi T; Takayanagi M; Fukao T; Fukuda S; Yamaguchi S
    Anal Bioanal Chem; 2013 Feb; 405(4):1345-51. PubMed ID: 23143007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine deficiency: Risk factors and incidence in children with epilepsy.
    Fukuda M; Kawabe M; Takehara M; Iwano S; Kuwabara K; Kikuchi C; Wakamoto H; Morimoto T; Suzuki Y; Ishii E
    Brain Dev; 2015 Sep; 37(8):790-6. PubMed ID: 25547040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine supplementation for inborn errors of metabolism.
    Nasser M; Javaheri H; Fedorowicz Z; Noorani Z
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD006659. PubMed ID: 22336821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of carnitine deficiency.
    Winter SC
    J Inherit Metab Dis; 2003; 26(2-3):171-80. PubMed ID: 12889658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine-acylcarnitine translocase deficiency is a treatable disease.
    al Aqeel AI; Rashed MS; Wanders RJ
    J Inherit Metab Dis; 1999 May; 22(3):271-5. PubMed ID: 10384385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carnitine deficiency].
    Schmidt-Sommerfeld E; Penn D
    Monatsschr Kinderheilkd; 1986 May; 134(5):224-31. PubMed ID: 3014317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine metabolism and human carnitine deficiency.
    Tanphaichitr V; Leelahagul P
    Nutrition; 1993; 9(3):246-54. PubMed ID: 8353366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors.
    Kumagai E; Hosohata K; Furumachi K; Takai S
    Ther Apher Dial; 2021 Oct; 25(5):595-606. PubMed ID: 33470531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and pathophysiology of carnitine deficiency, a predictable risk].
    Rodrigues Pereira R; Przyrembel H; Scholte HR
    Tijdschr Kindergeneeskd; 1990 Oct; 58(5):145-51. PubMed ID: 2247875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.